top of page
gradientForSurfBreak.png

Item List

Businesswire
Carlsmed Raises $52.5M in Series C Financing to Advance Personalized Spine Surgery

Carlsmed, an AI-enabled personalized surgery Medtech company, announced today a $52.5M Series C funding round co-led by B Capital and U.S. Venture Partners. These proceeds will be used to accelerate the commercialization of the aprevo® personalized spine surgery platform for lumbar fusion procedures and the development of aprevo® for cervical fusions, which will launch in 2025.

Recent Posts

General News

Carlsmed.png

Hospitals Work Through Fallout from CrowdStrike Outage ...

Modern Healthcare

General News

Carlsmed.png

Humana Makes Investment in AI-powered Medicare Enrollment Platform Healthpilot ...

Fierce Healthcare

General News

Carlsmed.png

Healthcare Costs Set to Rise by as Much as 8% in 2025: PwC ...

Fierce Healthcare

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page